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ABSTRACT 1 
Aims: The relationship between life-course body mass index (BMI) trajectories and 2 
adult risk for cardiovascular disease (CVD) is poorly described. In a well-characterized 3 
longitudinal cohort, we aimed to identify BMI trajectories from early childhood to 4 
adulthood and investigate their association with CVD risk factors (type 2 diabetes 5 
mellitus (T2DM), high-risk lipid levels, hypertension, and high carotid intima-media 6 
thickness (cIMT)) in adulthood (34 - 49 years). 7 
 8 
Methods and results: Six discrete long-term BMI trajectories were identified using 9 
Latent Class Growth Mixture Modelling among 2631 Cardiovascular Risk in Young 10 
Finns Study participants (6 to 49 years): stable normal (55.2%), resolving (1.6%), 11 
progressively overweight (33.4%), progressively obese (4.2%), rapidly 12 
overweight/obese (4.3%), and persistent increasing overweight/obese (1.2%). 13 
Trajectories of worsening or persisting obesity were generally associated with 14 
increased risk of CVD outcomes in adulthood (24-49 years) (all risk ratios, RRs, >15, 15 
p-values <0.05 compared with the stable normal group). Although residual risk for 16 
adult T2DM could not be confirmed (RR=2.6, CI=0.14–8.23), participants who 17 
resolved their elevated child BMI had similar risk for dyslipidemia and hypertension as 18 
those never obese or overweight (all RRs close to 1). However, they had significantly 19 
higher risk for increased cIMT (RR=3.37, CI=1.80–6.39).  20 
 21 
Conclusion: long-term BMI trajectories that reach or persist at high levels associate 22 
with CVD risk factors in adulthood. Stabilizing BMI in obese adults and resolving 23 
elevated child BMI by adulthood might limit and reduce adverse cardiometabolic 24 
 4 
profiles. However, efforts to prevent child obesity might be most effective to reduce 1 
the risk for adult atherosclerosis. 2 
 3 
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Introduction 1 
The prevalence of overweight and obesity has increased substantially in both adults 2 
and children1, 2. These trends are predicted to plateau in developed countries3, or to 3 
keep increasing globally, with a projected 1.35 billion overweight and 573 million 4 
obese adults by 20304. Child adiposity is associated with adverse long-term 5 
cardiovascular disease (CVD) risk2, 5-7. To date, epidemiologic studies examining 6 
associations between obesity and adult CVD risk have focused on body mass index 7 
(BMI) from a single or limited number of time-points6, 8, 9, ignoring the dynamic 8 
changes in BMI that occur over time and the potential diversity in child-to-adult BMI 9 
developmental patterns.  10 
 11 
Newer statistical techniques allow the investigation of the heterogeneity of BMI 12 
trajectories that might exist10-12. A number of studies have prospectively explored 13 
BMI trajectories in the periods of childhood, crossing over adolescence, using raw 14 
BMI or BMI z-scores10, 13-15, but none have covered a period long enough to 15 
encompass the life-course from young childhood until mid-adulthood. As a result, the 16 
progression of BMI from childhood into adulthood is less well-described16. Recent 17 
data suggest obese individuals who become non-obese between childhood and 18 
adulthood have a normalization of adult CVD risk8. However, it is unknown if the 19 
shape of BMI developmental patterns across the life-course, and in particular whether 20 
different patterns of high BMI incidence/resolution or stabilization from childhood to 21 
adulthood, play any role in predicting CVD risk in mid-adulthood. Determining if the 22 
development or resolution of abnormal BMI status at different ages predicts 23 
subsequent CVD risk might help inform public policy and interventions.  24 
 25 
 6 
Using data from the 31-year prospective Cardiovascular Risk in Young Finns Study 1 
(YFS), we aimed to identify subgroups of participants who share similar trajectories in 2 
BMI from childhood though mid-adulthood, and determine the independent association 3 
of these BMI trajectories with adult CVD outcomes.  4 
 7 
Methods  1 
Study sample  2 
Detailed descriptions of the YFS have been published previously17-19. This study 3 
considers a subset of 2631 YFS participants (1208 males, 1423 females) whose height 4 
and weight were measured on at least 3 occasions between 1980 and 2011. The 5 
minimum of 3 measures per participant included the initial childhood measure (1980), 6 
the last available BMI measure at any of the adult follow-ups (2001, 2007, or 2011), 7 
as well as one BMI measure between baseline and the last available BMI measure. 8 
BMI at each follow-up was calculated as 𝑊𝑒𝑖𝑔ℎ𝑡 (𝑘𝑔) 𝐻𝑒𝑖𝑔ℎ𝑡(𝑚)2⁄ . Participants 9 
were aged 6-18 years in 1980 and 34-49 years at the latest follow-up in 2011. On 10 
average, participants had 5.4 individual BMI records (71% had ≥5). BMI measures 11 
were not utilized if participants were currently pregnant. Participants or their parents 12 
provided written informed consent, and the study was approved by the Ethics 13 
Committee of the Hospital District of Southwest Finland. 14 
 15 
Definition of adult CVD outcomes  16 
Adult CVD risk outcomes of type 2 diabetes mellitus (T2DM), hypertension, and 17 
high-risk lipid levels were assessed in 2001, 2007, and 2011, whereas high-risk 18 
carotid intima-media thickness (cIMT) was assessed in 2001 and 2007. CVD 19 
outcomes at the latest available examination were considered using standard cut-offs.8 20 
A detailed description of the definition and the prevalence of each dichotomous 21 
outcome among the study sample, and the number of participants treated with lipid-22 
lowering-, blood-pressure-lowering and diabetes medications in adulthood is 23 
presented in Methods S1.  24 
Statistical Methods  25 
 8 
Latent BMI trajectories identification  1 
Heterogeneity in the longitudinal development of BMI was investigated using Latent 2 
Class Growth Mixture Modelling (LCGMM) to identify subgroups of YFS participants 3 
who shared similar underlying BMI trajectories between age 6 and 49 years. A series 4 
of LCGMM considering several polynomial specifications of BMI as a function of age 5 
and a number of variance-covariance structures for the random-effects were fit using 6 
the lcmm package in R20.  7 
The choice of the best model was based on different indices of goodness of fit and 8 
discrimination (Bayesian information Criteria (BIC), log-likelihood, proportion of 9 
subjects classified in each class with a posterior probability >0.7, and values of mean 10 
posterior class membership probabilities) as well as clinical plausibility20-22. The online 11 
supplement provides full details on the strategies used for model building, including 12 
specification of functional form and variance-covariance structure of the model, 13 
identification of the optimal number of distinct latent classes, and the computation and 14 
analyses of post-fit indices (Methods S2). 15 
 16 
Association of BMI trajectory groups with adult CVD outcomes 17 
To determine the association between trajectory groups and the different CVD risk 18 
factor outcomes in adulthood, the trajectory group memberships identified by LCGMM 19 
were introduced as predictors of each adult outcome in Poisson regression models with 20 
robust error variance. This method was chosen over logistic regression since the 21 
prevalence was larger than 10% for 5 out of 6 adult outcomes, and effect measures were 22 
thus reported in terms of relative risks rather than in odd ratios23-25.  23 
 24 
 9 
For a subset of 2421 participants (1073 males) who had all 6 CVD outcomes in 1 
adulthood, we constructed a combined cardiovascular load risk-score (range 0-6), 2 
calculated as the arithmetic sum of the number of adverse CVD outcomes at the latest 3 
adult follow-up (Table S1). The association between the BMI trajectory groups with 4 
the combined CVD risk load variable (classified as 0, 1, ≥2) was assessed using ordinal 5 
logistic regression. The adjusted models included year of birth and sex as covariates.  6 
 7 
  8 
 10 
Results 1 
Latent BMI trajectories 2 
Using BIC, class membership posterior probabilities and classification to assess the 3 
goodness-of-fit of the competing LGCMM models (Methods S2, Table S2), we 4 
identified 6 discrete life-course BMI trajectories among the 2631 YFS participants 5 
(Fig 1, Fig 2). 55.2% followed a trajectory where the average predicted BMI levels 6 
remained within normal weight status throughout follow-up (‘stable normal’ group, 7 
class 1, N=1453), 33.4% followed a trajectory of increasing BMI that led to 8 
overweight from the mid 30s (‘progressively overweight’ group, class 3, N=879), 9 
4.2% had BMI levels increasing rapidly from childhood, resulting in an overweight 10 
status in early adulthood and worsening obesity by early mid-adulthood 11 
(‘progressively obese’ group, class 4, N=110), 4.3% were borderline overweight in 12 
early childhood (age 6 years), overweight in mid-childhood (age 12 years) and obese 13 
but stabilizing by age 20 years (‘rapidly overweight/obese group’, class 5, N=113), 14 
1.2% followed a trajectory of persistent and increasing obesity throughout their 15 
observed life-course, leading to BMI levels ≥40 kg/m2 in mid-adulthood (‘persistent 16 
increasing overweight/obese’, class 6, N=33), and 1.6% were overweight or obese in 17 
childhood increasing to obese by 25 years but progressively reversed their elevated 18 
BMI status between 30 and 50 years of age (‘resolving’ group, class 2, N=43). 19 
Although some of the identified latent classes had low percentages of participants 20 
(<6%), they were highly discriminated with high mean a posteriori probabilities and 21 
high posterior probabilities (Table S2, Methods S2).  Table S3 provides parameter 22 
estimates of the fixed and random components of the 6-class quadratic mixture model. 23 
The considered age range was represented in all 6 classes, but there were differences 24 
in the average age across follow-ups, as well as the mean age at baseline. Sex 25 
 11 
differences were noted in specific classes of trajectories. Females were over-1 
represented in the ‘stable normal’ trajectory group, but the ‘progressively overweight’ 2 
(class 3) and ‘rapidly overweight/obese’ (class 5) groups, contained more males 3 
(Table 1). The ‘progressively obese’, ‘persistent increasing overweight /obese’ and 4 
‘resolving’ groups (classes 4, 6, and 2) had more females. 5 
 6 
Association of BMI trajectory groups with adult CVD outcomes 7 
The proportion of adult T2DM, hypertension, high-risk low-density lipoprotein 8 
(LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, and 9 
cIMT in the considered sample is shown in Table 2. Compared with participants 10 
classified in the ‘stable normal’ class (class 1), all BMI classes with worsening or 11 
persisting obesity (i.e. classes 3-6) had significantly higher risk for all considered 12 
adult outcomes. For those in the ‘resolving’ group (class 2, N=43), the estimated 13 
differences in risk were not consistent in direction across individual cardiometabolic 14 
traits. The risk ratio (RR) of hypertension, high-risk LDL-cholesterol and high-risk 15 
HDL-cholesterol were similar to those in class 1 (RRs close to 1), but the risk for 16 
T2DM was increased (RR=2.13, CI=0.14–8.23), and the risk for high-risk 17 
triglycerides was decreased slightly (RR=0.78, CI=0.09–2.4) (Table 2), although the 18 
confidence intervals for these estimates were too wide and included one. In contrast, 19 
participants in the resolving group (class 2) had nearly 3.5 times the risk for abnormal 20 
cIMT compared with participants in the normal stable BMI trajectory group 21 
(RR=3.37, CI=1.80–6.39, p-value<0.01, Table 2). Additional outcome, class specific 22 
results, and their interpretations are detailed in Table 3. Although the direction of 23 
effects remained similar, estimates for most outcomes attenuated towards the null 24 
after further adjustment for family history, adult socio-economic status, and adult 25 
 12 
physical activity level (Table 2). In contrast, RRs below one (class 2) for hypertension 1 
and high-risk triglycerides outcomes became stronger upon adjustment, but 2 
confidence intervals included 1.  3 
 4 
The probability of observing a non-null cumulative CVD risk load (i.e. having 1 or 5 
more CVD risk factor in adulthood) increased from 0.2 to 0.7 as BMI trajectory 6 
changed from ‘stable normal’ (class 1) to the ‘persistent increasing overweight/obese’ 7 
group (class 6) (Fig 3). The probability of having 2 or more CVD outcomes in 8 
adulthood was 11 times higher in the ‘persistent increasing overweight/obese’ group 9 
compared with the ‘stable normal’ group. The ‘resolving’ class was more likely than 10 
the ‘progressively overweight’ to maintain an ideal cardiometabolic profile (0.58 vs. 11 
0.43 probability of having 0 outcomes). 12 
 13 
  14 
 13 
Discussion 1 
We investigated how distinct long-term BMI trajectories observed between 6 and 49 2 
years of age influence later CVD risk. Our findings are consistent with previous 3 
studies showing that “excess BMI-years” increase risk of T2DM16, 26 and CVD risk 4 
factor levels.  Our observational data suggest that stabilizing BMI among obese adults 5 
could help limit their adverse CVD risk profiles and that reversing high BMI in young 6 
adulthood may lead to better cardiometabolic profiles than remaining stable 7 
overweight. Our results suggest that to effectively attenuate preclinical atherosclerosis 8 
risk, obesity prevention should ideally target children.  9 
 10 
The more than doubled risk difference observed for adult T2DM in the resolving class 11 
compared to the normal stable class suggested a potential residual effect of child 12 
overweight/obesity on adult T2DM risk, even with resolution of BMI status later in 13 
life. However, because the confidence intervals for this estimate included the null, this 14 
finding needs to be confirmed in further studies with a larger number of resolvers. 15 
Our results suggest that the absence of BMI stabilization in adulthood, rather than the 16 
age of obesity onset, is strongly associated with adult T2DM, hypertension, and high-17 
risk lipid levels. This is consistent with an observational study reporting the risk of 18 
T2DM was mainly associated with increased BMI levels close to the time of 19 
diagnosis16. In contrast, the cumulative burden of the number of life-years spent obese 20 
may be a stronger predictor of the adult risk of hypertension. Our findings also 21 
suggest that the mechanism by which excess BMI may increase circulating LDL-22 
cholesterol and triglycerides is primarily immediate and that a longer exposure to 23 
obesity does not additionally increase the risk of developing abnormal lipids beyond 24 
the level of BMI attained. Although the direction of risk estimates was not consistent 25 
 14 
across considered metabolic traits, these data suggest that completely reversing high 1 
BMI, even after childhood, is beneficial for most outcomes. However, this risk 2 
reduction was not observed for high cIMT.  3 
 4 
For cIMT, the data suggest that elevated BMI status in early life may alter arterial 5 
structure in a way that is not reversible, and that the effect of youth 6 
overweight/obesity on the risk for adult pre-atherosclerosis may not be correctable, 7 
even when weight status is normalized later in life1. This finding is in accordance with 8 
recent clinical studies suggesting childhood obesity may initiate pathogenic processes 9 
in the arterial wall that persist even with later improvements in body weight9, 27, and 10 
an observational study among male defense force recruits where elevated BMI at age 11 
17 years was associated with later coronary heart disease, independent of adult BMI 12 
levels16. Taken together, these data are consistent with atherosclerosis development 13 
occurring across the life-course such that a longer history of relative 14 
overweight/obesity starting earlier in life contributes additional, residual risk unable 15 
to be reversed by weight correction later in life. In contrast, our findings contradict 16 
those reported in a recent longitudinal study where reductions in BMI category, even 17 
if not sustained throughout the life-course, were associated with decreased cIMT28. 18 
However, there were a number of differences between cohorts and approaches and 19 
compared with our study, the emphasis was on the effect of weight loss at any age in 20 
adulthood, rather than the effect of long-term developmental patterns of BMI.  21 
 22 
Our data provides additional granularity of clinical importance to previous analyses 23 
from the YFS that suggested overcoming excess childhood adiposity by adulthood led 24 
to a normalization of all CVD risk outcomes in adulthood8. These analyses involved 25 
 15 
subjective categorization of participants into four groups based on their movement 1 
between BMI status between two examinations (performed up to 31 years apart) in 2 
childhood and adulthood. In addition, ‘true adiposity resolvers’ (i.e. overweight or 3 
obese children who became normal weight adults), could not be distinguished from 4 
‘adiposity improvers’ (i.e. overweight or obese children who became normal weight 5 
or overweight adults, respectively), or ‘overweight persistent’ (i.e. those overweight 6 
children who became overweight adults). Despite a high prevalence of adult 7 
overweight in our sample (reaching up to 36% overweight adults in 2011, Table S4), 8 
the previous approach collapsed ‘overweight’ and ‘normal-weight’ adults into a single 9 
category, preventing the discrimination of CVD risk between incident overweight and 10 
truly normative BMI trajectories. Therefore, it is possible the misclassification of 11 
participants in this group prevented detection of the residual effect of elevated 12 
childhood BMI on adult cIMT risk that we noted here8. 13 
 14 
Distinct life-course progressions of CVD risk factors have been shown to associate 15 
with subsequent CVD risk29-31. Consistent with our findings, recent studies suggest 16 
the cardiovascular consequences of obesity are cumulative, and that the duration of 17 
overweight or obesity may be a stronger predictor of CVD outcomes compared with a 18 
cruder measure of obesity-resolution or obesity-onset between two time-points5, 32, 33. 19 
Beyond the number of years spent living with an adverse weight status, the 20 
developmental period (childhood, puberty, mid-adulthood) at obesity onset, or the age 21 
at obesity resolution, may itself contribute to the strength of the association between 22 
change in BMI status and CVD outcomes34, 35. To overcome issues associated with 23 
discrete categorization of participants based on dichotomous measures of obesity or 24 
overweight at different ages36, 37, a life-course perspective provides a useful avenue to 25 
 16 
evaluate the impact of long-term BMI trajectory patterns on later-life CVD risk. 1 
Indeed, rather than modelling trajectories as individual deviation from population 2 
average age-BMI curves11, identifying groups of individuals with similar patterns of 3 
BMI trajectories compliments individual-based approaches, as it can increase our 4 
understanding of how weight status fluctuations, and different pathways of obesity 5 
onset and development, impact subsequent CVD risk. 6 
 7 
This study had several strengths. Our study includes a period large enough to examine 8 
the heterogeneity in BMI trajectories from childhood until mid-adulthood that 9 
allowed us to quantify adult CVD risk in groups of participants whose weight 10 
trajectories remained poorly described in previous studies.10, 13-15. In addition, the 11 
LCGMM approach used in this study allowed the a-posteriori identification of 12 
qualitatively distinct BMI trajectories in our data, thus overcoming misclassification 13 
and loss of information that can arise when defining groups of trajectories a-priori. 14 
Limitations included the lack of BMI observations in early childhood (<6 years) that 15 
precluded us from considering the critical period of adiposity rebound; the inclusion 16 
of a large racially-homogenous cohort of Northern European ancestry that could limit 17 
generalizability; and the lack of longitudinal measures on other indices of adiposity 18 
that might better reflect fat distribution and subcutaneous fat than BMI.  19 
 20 
In conclusion, BMI trajectories from childhood to adulthood vary, with trajectories 21 
that reach or persist at high levels associated with an increased cumulative CVD risk 22 
load in mid-adulthood. The results for the individual cardiometabolic outcomes, 23 
however, are complex and not all consistent in direction. Our results suggest that the 24 
absence of BMI stabilization in adulthood may be a stronger determinant of adult 25 
 17 
T2DM risk compared with the age at which obesity developed. In addition, the risk 1 
for adult hypertension was stronger among trajectory groups that developed high BMI 2 
early in life and were therefore obese for many years. Despite non-statistically 3 
significant estimates (probably attributable to small sample size), complete resolution 4 
of high-BMI appears to be associated with a normalization of risk for adverse lipid 5 
levels and hypertension in adulthood, although it is possible that some residual risk 6 
exists for T2DM. Together, the data suggests that resolving high adiposity even in 7 
young adulthood may be beneficial to long-term CVD risk. However, the markedly 8 
increased risk for high-risk cIMT in middle adulthood despite body weight 9 
normalization between childhood and adulthood emphasizes the potential importance 10 
of childhood obesity prevention to attenuate the risk of preclinical atherosclerosis.   11 
  12 
 18 
Figure legends 1 
 2 
Fig 1. Distinct latent body mass index (BMI) trajectories identified from childhood to 3 
adulthood in the Cardiovascular Risk in Young Finns Study from 6-49 years. Solid 4 
lines show class-specific mean predicted BMI levels as a function of age estimated 5 
from best fitting growth mixture model (6-class quadratic LGCMM). Dashed lines 6 
indicate estimated 95% confidence intervals, and shaded background areas indicate 7 
normal (green), overweight (blue), and obese BMI status (red) across the observed 8 
life-course (international childhood sex-specific cut points38, were averaged across 9 
sex at each age to improve readability). Number of participants attributed to each 10 
latent class is shown in the legend. 11 
 12 
Fig 2. Individual long-term body mass index (BMI) profiles within each identified 13 
latent trajectory class. Shown are the observed individual BMI profiles, colour-coded 14 
according to posterior BMI trajectory class membership (thin lines). Solid lines show 15 
the loess-smoothed BMI trajectories for the 6 identified latent classes (obtained by 16 
smoothing across all BMI profiles attributed to each latent class). 17 
 18 
Fig 3. Predicted probability of having a cumulative cardiovascular disease (CVD) risk 19 
load of 0 (N=1360), 1 (N=540) and ≥2 (N=521) in the Cardiovascular Risk in Young 20 
Finns Study for each latent body mass index (BMI) trajectory class. The predicted 21 
probability plot is derived from the proportional odd ratios estimated for the sex- and 22 
adult age-adjusted ordinal logistic model.23 
 19 















 (class 1) (class 2) (class 3) (class 4) (class 5) (class 6)  
 N=1453 N=43 N=879 N=110 N=113 N=33  
Mean age (sd) (years) 
25.11 
(12.8) 
22.33 (12.6) 21.43 (12.0) 23.62 (12.7) 24.76 (12.5) 24.72 (12.5) 0.001 
Min age–Max age (years) 6-49 6-49 6-49 6-49 6-49 6-49 1 
Mean age baseline (sd) 
(years) 
12.11 (4.2) 11.83 (4.0) 9.91 (3.8) 11.46 (4.0) 11.93 (3.9) 9.97 (3.6) <0.001 
Male, % 37.7 46.5 59.6 39 53.1 36.3 0.02 
* p-values from Anova F-tests (comparisons of means) and from chi-square tests of independence (comparison of proportions). 
sd = standard deviation.
 20 
Table 2. Sex and year of birth adjusted risk ratios (RR), 95% confidence intervals (CI), and Wald z-statistic p-values between body mass index 
(BMI) trajectory group and adult outcomes. Results of univariate models are presented in the first 3 columns, results in the greyed-out columns 
are those of models further adjusted for family history of each outcome, adult socio-economic status, and physical activity level in adulthood. 
 
 
Outcome, Latent  
BMI trajectory group 
%f RRc 95%CIc P-value  RRc 95%CIc P-value  
Type 2 diabetes 3.5       
Class 1a 1.4 1b - - 1 - - 
Class 2 2.6 2.13 0.14–8.23 0.31 1.93 0.11 – 9.73 0.40 
Class 3 3.5 2.49 1.38–4.58 0.002 2.09 1.09 – 5.11 0.02 
Class 4 17.1 13.05 6.71–25.17 6.75x10-15 10.1 3.13 – 19.72 0.03 
Class 5 12.6 9.33 4.39–19.08 1.1x10-9 9.33 4.12 – 16.15 0.002 
 21 
Class 6 20.1 19.45 8.63–31.16 7.5x10-10 16.5 6.30 – 22.61 0.01 
Hypertensione 26.6       
Class 1a 19.3 1 -  1 -  
Class 2 17.1 0.76 0.23–1.80 0.25 0.52 0.13 – 1.32 0.15 
Class 3 26.9 1.64 1.36–1.99 2.3x10-9 1.24 1.11 –1.99 0.04 
Class 4 33.1 2.20 1.52–3.08 1.1x10-6 2.12 1.15–2.89 0.02 
Class 5 36.5 2.35 1.65–3.26 2.9x10-8 2.28 1.32–3.02 <0.01 
Class 6 40.6 3.18 1.77–5.35 1.6x10-5 2.98 1.51–5.02 0.03 
High-risk cIMTe 13.1       
Class 1a 7.8 1b -  1 -  
Class 2 25.1 3.37 1.80–6.39 4.3x10-6 3.12 1.51 –6.03 0.04 
Class 3 13.3 1.70 1.30–2.22 4.1x10-3 1.31 1.01–2.14 <0.01 
 22 
Class 4 22.3 2.68 1.78–4.40 1.3x10-6 2.19 1.31 –3.90 <0.01 
Class 5 24.5 3.27 2.11–4.90 6.6x10-9 3.10 1.92 –3.45 0.02 
Class 6 25.8 3.49 2.32–5.71 0.002 3.14 2.21 –4.12 <0.01 
High-risk LDL-Ce  15.2       
Class 1a  9.4 1b - - 1b - - 
Class 2  10.5 1.03 0.14–1.10 0.10 1.01 0.1 – 1.08 0.45 
Class 3  16.5 1.47 1.16–1.84 3.5x10-5 1.12 1.06 – 1.49 0.02 
Class 4  17.9 1.59 1.37–1.95 0.04 1.30 1.17 – 2.57 0.05 
Class 5  18.7 1.65 1.21–2.63 0.006 1.20 1.11 – 2.30 0.03 
Class 6  19.8 1.78 1.11–2.72 0.023 1.51 1.05 – 2.94 0.05 
High-risk HDL-Ce 24.4       
 23 
Class 1a 11.4 1 -  1 -  
Class 2 14.6 1.07 0.72–1.19 0.16 1.03 0.22 – 1.11 0.36 
Class 3 26.3 1.57 1.16–1.84 2.1x10-11* 1.24 1.12 –1.82 0.03 
Class 4 41.8 1.75 1.04–12.1 1.1x10-16 1.35 1.01–12.1 <0.01 
Class 5 39.9 1.72 1.10–2.72 1.9x10-9 1.41 1.02 –2.22 <0.01 
Class 6 40.6 1.77 1.56–2.96 2.45x10-3 1.37 1.26–2.60 0.04 
High-risk triglyceridese 12.5       
Class 1a 4.8 1b -  1 -  
Class 2 4.5 0.78 0.09–2.4 0.42 0.31 0.06 –2.12 0.42 
Class 3 17.7 3.06 2.31–4.10 2.1x10-15 2.89 2.02–4.08 <0.01 
Class 4 27.7 5.62 3.61–8.53 3.6x10-16 5.11 3.11 –9.58 0.03 
 24 
Class 5 25.6 4.73 3.02–7.23 4.3x10-15 4.24 3.02 –7.34 0.02 
Class 6 18.9 4.03 1.56–8.56 0.0001 3.21 1.22 –9.60 0.04 
 
aLatent BMI trajectory classes: Class 1, Stable normal trajectory (N=1453); Class 2, Resolving (N=43); Class 3, Progressively overweight 
(N=879); Class 4, Progressively obese (N=110); Class 5, Rapidly overweight/obese (N=113); and Class 6, Persistent increasing 
overweight/obese (N=33). 
 
bClass1 is the reference group. Unadjusted models with only the trajectory groups were also fit but estimated RRs were not significantly different 
and the AIC suggested that the sex-and year of birth (YOB) adjusted models fit the data better (data not shown). 
 
cfor each latent class the RRs can be interpreted as the changes in relative ratios for belonging to a given class, vs. the reference class (here class 
1). (i.e. a [RR] of 1.0, means there is no difference in risk between the trajectory group tested and the reference group. A RR of 0.5 means a 50% 
lower risk, and a RR of 1.5 means a 50% higher risk compared to reference. 
 
dThe 95%CI for the relative risks was obtained by log-likelihood profiling of the robust standard errors. 
 
eType 2 diabetes mellitus (T2DM) was defined as having fasting plasma glucose level of ≥7 mmol/l (126 mg/dl), or reporting the use of oral 
glucose-lowering medication or insulin but not reporting having type 1 diabetes, or receiving a diagnosis of T2DM from a physician at any of 
their adult follow-up examinations (2001, 2007, or 2011). Hypertension was defined as having a systolic blood pressure of ≥140 mmHg or a 
diastolic blood pressure of ≥90 mmHg, or reporting the used of blood pressure–lowering medication. High-risk LDL-cholesterol was defined as 
having levels of ≥160 mg/dl (4.14 mmol/l) or reporting currently taking lipid-lowering medication. High-risk HDL-cholesterol was defined as 
having levels of <40 mg/dl (1.03 mmol/l). High-risk triglyceride was defined as having levels of ≥200 mg/dl (2.26 mmol/l) or higher39. High-risk 
cIMT was defined as cIMT values ≥90th percentile for age-, and sex-specific values. 
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f: Proportion of participants (%) with each adult outcome in the considered sample and within each trajectory class.  
 
cIMT = carotid intima-media thickness; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol. 
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Table 3. Additional class specific results and their interpretations for the considered adult outcomes. 
 
BMI = body mass index; cIMT = carotid intima-media thickness; CVD = cardiovascular disease; HDL-C = high-density lipoprotein cholesterol; 




T2DM	 • Among obese adults, those whose BMI kept increasing in adulthood (classes 4 and 
6) had greater risks of developing T2DM compared with those whose obesity 
developed sooner in life but stabilized in their early adulthood (class 5). (RR=1.4 
(1.02-2.1) and RR=2.8 (1.2-4.3), respectively).	
•  The ‘progressively obese’ group (class 4) and the ‘persistent increasing 
overweight/obese’ group (class 6) had the highest risks of T2DM,	
• The risk of T2DM for these participants (classes 4 and 6) are up to 7 times higher 
compared to participants in the ‘Reversing’ group (class 2) (RR=4.8 (1.1-20.8) and 
RR=7.3 (1.3-34.2), respectively), and those whose BMI stabilized to overweight 
levels (class 3)) (RR=5.2 (2.8-9.6) and RR=7.8 (2.8-14.2), respectively).	
• Worsening obesity in adulthood increases 
risk for  





• Reversing obesity or avoiding to become 
obese translates into a significant 
reduction or risk for adult T2DM. 
High-cIMT	 • Participants in the ‘Resolving’group (class 2) still have nearly 3.5 times the risk for 
abnormal cIMT compared with participants who maintained a non-
overweight/obese BMI from childhood to adulthood (class 1) (RR=3.37 (1.8-6.39).	
• The effect of youth obesity on the risk for 
adult pre-atherosclerosis may not be 
reversible even with the normalization of 
high-BMI in later life.	
Hypertension	 • For hypertension, the risk ratios appeared smaller in the ‘Resolving’group (class 2) 
compared with the incident overweight participants (class 3) (RR=0.59 (0.15-1.2), 
but were incremental in classes 4, 5 and 6 (RR=1.7 (1.2-2.4), RR=1.9 (1.4-2.6), and 
RR=2.5 (1.6-4.1), respectively).	
• Resolving youth obesity may reduce risk 
of adult hypertension. 	
• The number of years spent obese may be 
an important determinant of adult 
hypertension.	
High-risk	lipids	 • The risk of raised adult LDL-C is similar in the ‘Resolving’ (class 2) and the ‘stable 
normal’ groups (class 1) (RR=1.03 (0.14-1.1), but ~1.5 higher in the incident 
overweight group (class 3) (RR=1.47 (1.16-1.84), Participants obese in adulthood 
(classes 4, 5 and 6) had close to twice the risk of developing abnormal LDL-C 
levels. (RR=1.6 (1.4-1.9), RR=1.7 (1.2-2.6), and RR=1.8 (1.1-2.7), respectively).	
• High triglycerides level was ~3 times more likely in the incident overweight group 
(class 3) compared with the normal stable group (class 1) (RR=3.06 (2.3-4.1)). The 
highest risk was for those who became obese in adulthood (class 4) (RR=5.6 (3.6-
8.5)).	
• Participants who became overweight or obese had greater risks of having lower 
HDL-C levels in mid-adulthood, especially those with persisting and increasing 
obesity (class 6) (all RRs >1.5 for classes 3 to 6).	
• A longer exposure to obesity may not 
additionally increase the risk of 
developing abnormal LDL-C, HDL-C 
and triglycerides levels (immediate effect 
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